These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 27694336)

  • 1. Patient- and clinician-reported outcomes for patients with new presentation of inflammatory arthritis: observations from the National Clinical Audit for Rheumatoid and Early Inflammatory Arthritis.
    Ledingham JM; Snowden N; Rivett A; Galloway J; Ide Z; Firth J; MacPhie E; Kandala N; Dennison EM; Rowe I
    Rheumatology (Oxford); 2017 Feb; 56(2):231-238. PubMed ID: 27694336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Achievement of NICE quality standards for patients with new presentation of inflammatory arthritis: observations from the National Clinical Audit for Rheumatoid and Early Inflammatory Arthritis.
    Ledingham JM; Snowden N; Rivett A; Galloway J; Ide Z; Firth J; MacPhie E; Kandala N; Dennison EM; Rowe I
    Rheumatology (Oxford); 2017 Feb; 56(2):223-230. PubMed ID: 27694337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The first national clinical audit for rheumatoid arthritis.
    Firth J; Snowden N; Ledingham J; Rivett A; Galloway J; Dennison EM; MacPhie E; Ide Z; Rowe I; Kandala N; Jameson K;
    Br J Nurs; 2016 Jun 9-22; 25(11):613-7. PubMed ID: 27281595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validity of the rheumatoid arthritis impact of disease (RAID) score and definition of cut-off points for disease activity states in a population-based European cohort of patients with rheumatoid arthritis.
    Salaffi F; Di Carlo M; Vojinovic J; Tincani A; Sulli A; Soldano S; Andreoli L; Dall'Ara F; Ionescu R; Simić Pašalić K; Balčune I; Ferraz-Amaro I; Tlustochowicz M; Butrimienė I; Punceviciene E; Toroptsova N; Grazio S; Morović-Vergles J; Masaryk P; Otsa K; Bernardes M; Boyadzhieva V; Cutolo M
    Joint Bone Spine; 2018 May; 85(3):317-322. PubMed ID: 28549945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-reported Outcomes as Predictors of Change in Disease Activity and Disability in Early Rheumatoid Arthritis: Results from the Yorkshire Early Arthritis Register.
    Twigg S; Hensor EMA; Emery P; Tennant A; Morgan AW;
    J Rheumatol; 2017 Sep; 44(9):1331-1340. PubMed ID: 28668806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a national audit tool for juvenile idiopathic arthritis: a BSPAR project funded by the Health Care Quality Improvement Partnership.
    McErlane F; Foster HE; Armitt G; Bailey K; Cobb J; Davidson JE; Douglas S; Fell A; Friswell M; Pilkington C; Strike H; Smith N; Thomson W; Cleary G
    Rheumatology (Oxford); 2018 Jan; 57(1):140-151. PubMed ID: 29069424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining cut-off values for disease activity states and improvement scores for patient-reported outcomes: the example of the Rheumatoid Arthritis Impact of Disease (RAID).
    Dougados M; Brault Y; Logeart I; van der Heijde D; Gossec L; Kvien T
    Arthritis Res Ther; 2012 May; 14(3):R129. PubMed ID: 22647431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychometric properties of sleep and coping numeric rating scales in rheumatoid arthritis: a subanalysis of an etanercept trial.
    Avila-Ribeiro P; Brault Y; Dougados M; Gossec L
    Clin Exp Rheumatol; 2017; 35(5):786-790. PubMed ID: 28339355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the utility of visual feedback in the treatment of early rheumatoid arthritis patients: a pilot study.
    El Miedany Y; El Gaafary M; Palmer D
    Rheumatol Int; 2012 Oct; 32(10):3061-8. PubMed ID: 21909946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-reported outcomes in Asia: evaluation of the properties of the Rheumatoid Arthritis Impact of Disease (RAID) score in multiethnic Asian patients with rheumatoid arthritis.
    Cheung PP; Lahiri M; March L; Gossec L
    Clin Rheumatol; 2017 May; 36(5):1149-1154. PubMed ID: 28039541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and therapeutic delay of rheumatoid arthritis and its relationship with health care devices in Catalonia. The AUDIT study.
    Corominas H; Narváez J; Díaz-Torné C; Salvador G; Gomez-Caballero ME; de la Fuente D; Campoy E; Roig-Vilaseca D; Clavaguera T; Morlà R; Torrente-Segarra V; Arasa X; Gomez-Puerta JA; Möller I; Alegre C; Graell E; Ponce A; Lisbona MP; Pérez-Garcia C; Fíguls R; Sirvent E; Poca V; Sanmartí R
    Reumatol Clin; 2016; 12(3):146-50. PubMed ID: 26362843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the Rheumatoid Arthritis Impact of Disease (RAID) Score in Assessing Rheumatoid Arthritis Activity in Teleconsultation.
    Avouac J; Molto A; Allanore Y
    J Rheumatol; 2024 Oct; 51(10):973-977. PubMed ID: 38825352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Data quality predicts care quality: findings from a national clinical audit.
    Yates M; Bechman K; Dennison EM; MacGregor AJ; Ledingham J; Norton S; Galloway JB
    Arthritis Res Ther; 2020 Apr; 22(1):87. PubMed ID: 32303251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis.
    Symmons D; Tricker K; Roberts C; Davies L; Dawes P; Scott DL
    Health Technol Assess; 2005 Sep; 9(34):iii-iv, ix-x, 1-78. PubMed ID: 16153351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Routine Assessment of Patient Index Data 3 (RAPID3) alone is insufficient to monitor disease activity in rheumatoid arthritis in clinical practice.
    Boone NW; Sepriano A; van der Kuy PH; Janknegt R; Peeters R; Landewé RBM
    RMD Open; 2019; 5(2):e001050. PubMed ID: 31908842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Onset of action of etanercept in rheumatoid arthritis based on patient-reported outcomes.
    Dougados M; Ripert M; Hilliquin P; Brocq O; Brault Y; Logeart I
    Clin Exp Rheumatol; 2012; 30(2):266-8. PubMed ID: 22325048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European multicentre pilot survey to assess vitamin D status in rheumatoid arthritis patients and early development of a new Patient Reported Outcome questionnaire (D-PRO).
    Vojinovic J; Tincani A; Sulli A; Soldano S; Andreoli L; Dall'Ara F; Ionescu R; Pasalic KS; Balcune I; Ferraz-Amaro I; Tlustochowicz M; Butrimiene I; Punceviciene E; Toroptsova N; Grazio S; Morovic-Vergles J; Masaryk P; Otsa K; Bernardes M; Boyadzhieva V; Salaffi F; Cutolo M
    Autoimmun Rev; 2017 May; 16(5):548-554. PubMed ID: 28279841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab therapy in patients with rheumatoid arthritis refractory or with contraindication to anti-tumour necrosis factor drugs: real-life experience in Finnish patients.
    Valleala H; Korpela M; Möttönen T; Hienonen-Kempas T; Kauppi M; Hannonen P; Leirisalo-Repo M
    Scand J Rheumatol; 2009; 38(5):323-7. PubMed ID: 19585384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of pain score measured by a visual analog scale (PS-VAS) on the Health Assessment Questionnaire Disability Index and 28-joint Disease Activity Index with C-reactive protein in rheumatoid arthritis patients.
    Yoshii I; Chijiwa T; Sawada N
    Int J Rheum Dis; 2018 Nov; 21(11):1955-1961. PubMed ID: 30175554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three out of four disease-modifying anti-rheumatic drug-naïve rheumatoid arthritis patients meet 28-joint Disease Activity Score remission at 12 months: results from the FIN-ERA cohort.
    Rannio T; Asikainen J; Hannonen P; Yli-Kerttula T; Ekman P; Pirilä L; Kuusalo L; Mali M; Puurtinen-Vilkki M; Kortelainen S; Paltta J; Taimen K; Kauppi M; Laiho K; Nyrhinen S; Mäkinen H; Isomäki P; Uotila T; Aaltonen K; Kautiainen H; Sokka T
    Scand J Rheumatol; 2017 Nov; 46(6):425-431. PubMed ID: 28367663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.